Immunovant, Inc. (IMVT)
25.35
-0.26
(-1.02%)
USD |
NASDAQ |
Dec 30, 16:00
25.33
-0.02
(-0.08%)
After-Hours: 20:00
Immunovant Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Revvity, Inc. | 6.76% |
| Viridian Therapeutics, Inc. | -49.03% |
| Perspective Therapeutics, Inc. | -12.43K% |
| Electromed, Inc. | 12.65% |
| Xtant Medical Holdings, Inc. | 3.93% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -88.10% |
| Return on Assets | -78.54% |
| Return on Invested Capital | -88.09% |
| Return on Net Operating Assets | -16.73K% |